Balesse Pharma SRL
Balesse Pharma reported total assets of 20,519 € at the end of the 2025 financial year (annual accounts filed with the NBB on 07 Aug 2026).
The score of Balesse Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Balesse Pharma's annual accounts
| 2025 | |
|---|---|
| Net result | 8,485 € |
| Equity | 12,652 € |
| Cash | 13,332 € |
| EBITDA | 11,236 € |
| Total assets | 20,519 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 07 Aug 2026
Balesse Pharma's financial analysis
- Solvency61.7%sector median: 55.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Balesse Pharma
Balesse Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1023.941.304
- VAT number
- BE1023941304
- Peppol
- Registered · 0208:1023941304 · as of 11 Nov 2026
- Legal form
- SRL
- Incorporated
- 03 Jun 2025
- Registered office
- 2600 Antwerp
- Latest accounts
- 2025 · filed on 07 Aug 2026
- Activity
- Other business support service activities n.e.c. (NACE 82990)
Balesse Pharma (SRL) has been based in Antwerp since 2025, active in: other business support service activities n.e.c.. For 2025, it reports a net profit of 8,485 € and equity of 12,652 €; its revenue is not published. Its solvency stands at 61.7%, above the median of its sector (55.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Balesse Pharma
Companies in the same business, of comparable size and area, outside its group.
- Eline Lambert Pharmaconsult & Investments Other business support service activities n.e.c. Antwerp · balance sheet 49,862 €
- Molostar Other non-specialised retail sale Antwerp · balance sheet 53,758 €
- iRISE Other business support service activities n.e.c. Antwerp · balance sheet 28,659 €
- WDM Other business support service activities n.e.c. Staden · balance sheet 20,547 €
- COM-Art Other business support service activities n.e.c. Celles (lez-Tournai) · balance sheet 20,345 €
- IWC Other business support service activities n.e.c. Lendelede · balance sheet 238,365 €
- Precis Service Other business support service activities n.e.c. Braine-l'Alleud · balance sheet 59,277 €
- Helix Consult Other business support service activities n.e.c. Bruges · balance sheet 24,166 €
Frequently asked questions about Balesse Pharma
What is the revenue of Balesse Pharma?
Balesse Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Balesse Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE1023941304 for Balesse Pharma, if the company is VAT-registered. Its company number (CBE) is 1023.941.304.
Where is the registered office of Balesse Pharma?
According to the CBE register, the registered office of Balesse Pharma is in 2600 Antwerp.
What is the equity of Balesse Pharma?
At the close of the 2025 financial year, the equity of Balesse Pharma amounts to 12,652 €, a solvency of 61.7% of total assets.
Who manages Balesse Pharma?
The register lists 1 active mandates at Balesse Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Balesse Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →